{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,7,25]],"date-time":"2024-07-25T06:38:33Z","timestamp":1721889513353},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"S1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Bioinformatics"],"published-print":{"date-parts":[[2011,12]]},"abstract":"Abstract<\/jats:title>\n \n Background<\/jats:title>\n HSPs (Heat shock proteins) are highly conserved ubiquitous proteins among species which are involved in maintaining appropriate folding and conformation of other proteins and are thus referred to as molecular chaperones. Hsp90 (Heat-shock protein 90 kDa) is one of a group of molecular chaperones responsible for managing protein folding and quality control in cell environment. However it is also involved in the maturation and stabilization of a wide range of oncogenic client proteins which are crucial for oncogenesis and malignant progression. Hsp90 requires a series of co-chaperones to assemble into a super-chaperone complex for its function. These co-chaperones bind and leave the complex at various stages to regulate the chaperoning process. Arresting the chaperone cycle at these stages by targeting different co-chaperone\/Hsp90 interactions seems to be quite a viable alternative and is likely to achieve similar consequences as that of Hsp90 direct inhibition with added favors of high specificity and reduced side effect profile. The study conducted here is an attempt to explore the potential of Withania somnifera\u2019s<\/jats:italic> major constituent WA (Withaferin A) in attenuating the Hsp90\/Cdc37 chaperone\/co-chaperone interactions for enhanced tumor arresting activity and to elucidate the underlying mode of action using computational approaches.<\/jats:p>\n <\/jats:sec>\n \n Results<\/jats:title>\n Formation of active Hsp90\/Cdc37 complex is one of the essential steps for facilitation of chaperone client interaction, non-assembly of which can lead to prevention of the chaperone-client association resulting in apoptosis of tumor cells. From our flexible docking analysis of WA into active Hsp90\/Cdc37 complex in which key interfacing residues of the complex were kept flexible, disruption of the active association complex can be discerned. While docking of WA into segregated Hsp90 leaves the interface residues untouched. Thus the molecular docking analysis of WA into Hsp90 and active Hsp90\/Cdc37 complex conducted in this study provides significant evidence in support of the proposed mechanism of chaperone assembly suppression by inhibition or disruption of active Hsp90\/Cdc37 complex formation being accounted by non-assembly of the catalytically active Hsp90\/Cdc37 complex. Results from the molecular dynamics simulations in water show that the trajectories of the protein complexed with ligand WA are stable over a considerably long time period of 4 ns, with the energies of the complex being lowered in comparison to the un-docked association complex, suggesting the thermodynamic stability of WA complexed Hsp90\/Cdc37.<\/jats:p>\n <\/jats:sec>\n \n Conclusions<\/jats:title>\n The molecular chaperone Hsp90 has been a promising target for cancer therapy. Cancer is a disease marked by genetic instability. Thus specific inhibition of individual proteins or signalling pathways holds a great potential for subversion of this genetic plasticity of cancers. This study is a step forward in this direction. Our computational analysis provided a rationalization to the ability of naturally occurring WA to alter the chaperone signalling pathway. The large value of binding energy involved in binding of WA to the active Hsp90\/Cdc37 complex consolidates the thermodynamic stability of the binding. Our docking results obtained substantiate the hypothesis that WA has the potential to inhibit the association of chaperone (Hsp90) to its co-chaperone (Cdc37) by disrupting the stability of attachment of Hsp90 to Cdc37. Conclusively our results strongly suggest that withaferin A is a potent anticancer agent as ascertained by its potent Hsp90-client modulating capability.<\/jats:p>\n <\/jats:sec>","DOI":"10.1186\/1471-2105-12-s1-s30","type":"journal-article","created":{"date-parts":[[2011,2,18]],"date-time":"2011-02-18T20:11:33Z","timestamp":1298059893000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":58,"title":["Hsp90\/Cdc37 Chaperone\/co-chaperone complex, a novel junction anticancer target elucidated by the mode of action of herbal drug Withaferin A"],"prefix":"10.1186","volume":"12","author":[{"given":"Abhinav","family":"Grover","sequence":"first","affiliation":[]},{"given":"Ashutosh","family":"Shandilya","sequence":"additional","affiliation":[]},{"given":"Vibhuti","family":"Agrawal","sequence":"additional","affiliation":[]},{"given":"Piyush","family":"Pratik","sequence":"additional","affiliation":[]},{"given":"Divya","family":"Bhasme","sequence":"additional","affiliation":[]},{"given":"Virendra S","family":"Bisaria","sequence":"additional","affiliation":[]},{"given":"Durai","family":"Sundar","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2011,2,15]]},"reference":[{"issue":"6583","key":"4388_CR1","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1038\/381571a0","volume":"381","author":"FU Hartl","year":"1996","unstructured":"Hartl FU: Molecular chaperones in cellular protein folding. Nature 1996, 381(6583):571\u2013580. 10.1038\/381571a0","journal-title":"Nature"},{"issue":"10","key":"4388_CR2","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1038\/nrm1492","volume":"5","author":"JC Young","year":"2004","unstructured":"Young JC, Agashe VR, Siegers K, Hartl FU: Pathways of chaperone-mediated protein folding in the cytosol. Nat Rev Mol Cell Bio 2004, 5(10):781\u2013791. 10.1038\/nrm1492","journal-title":"Nat Rev Mol Cell Bio"},{"issue":"1289","key":"4388_CR3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1098\/rstb.1993.0031","volume":"339","author":"WJ Welch","year":"1993","unstructured":"Welch WJ: Heat-Shock Proteins Functioning as Molecular Chaperones - Their Roles in Normal and Stressed Cells. Philos T Roy Soc B 1993, 339(1289):327\u2013333. 10.1098\/rstb.1993.0031","journal-title":"Philos T Roy Soc B"},{"issue":"6","key":"4388_CR4","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.molmed.2004.04.006","volume":"10","author":"A Kamal","year":"2004","unstructured":"Kamal A, Boehm MF, Burrows FJ: Therapeutic and diagnostic implications of Hsp90 activation. Trends Mol Med 2004, 10(6):283\u2013290. 10.1016\/j.molmed.2004.04.006","journal-title":"Trends Mol Med"},{"issue":"16","key":"4388_CR5","first-page":"6126s","volume":"9","author":"A Kamal","year":"2003","unstructured":"Kamal A, Thao L, Sensintaffar J, Zhang L, Boehm MF, Fritz LC, Burrows FJ: A high-affinity conformation of Hsp90 confers tumor selectivity on Hsp90 inhibitors. Clin Cancer Res 2003, 9(16):6126s-6126s.","journal-title":"Clin Cancer Res"},{"issue":"28","key":"4388_CR6","doi-asserted-by":"publisher","first-page":"6350","DOI":"10.1016\/j.febslet.2005.10.020","volume":"579","author":"SF Falsone","year":"2005","unstructured":"Falsone SF, Gesslbauer B, Tirk F, Piccinini AM, Kungl AJ: A proteomic snapshot of the human heat shock protein 90 interactome. Febs Lett 2005, 579(28):6350\u20136354. 10.1016\/j.febslet.2005.10.020","journal-title":"Febs Lett"},{"key":"4388_CR7","first-page":"349","volume":"272","author":"R Zhao","year":"2005","unstructured":"Zhao R, Davey M, Hsu YC, Kaplanek P, Tong A, Parsons AB, Krogan N, Cagney G, Mai D, Greenblatt J, et al.: Navigating the chaperone network: an integrative map of physical, genetic, and chemical-genetic interactions mediated by the yeast Hsp90 chaperone system. Febs J 2005, 272: 349\u2013349.","journal-title":"Febs J"},{"issue":"5","key":"4388_CR8","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1021\/cb600224w","volume":"1","author":"G Chiosis","year":"2006","unstructured":"Chiosis G, Neckers L: Tumor selectivity of Hsp90 inhibitors: The explanation remains elusive. Acs Chem Biol 2006, 1(5):279\u2013284. 10.1021\/cb600224w","journal-title":"Acs Chem Biol"},{"key":"4388_CR9","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1042\/BJ20071640","volume":"410","author":"LH Pearl","year":"2008","unstructured":"Pearl LH, Prodromou C, Workman P: The Hsp90 molecular chaperone: an open and shut case for treatment. Biochem J 2008, 410: 439\u2013453. 10.1042\/BJ20071640","journal-title":"Biochem J"},{"issue":"27","key":"4388_CR10","doi-asserted-by":"publisher","first-page":"2839","DOI":"10.2174\/092986707782360079","volume":"14","author":"C Didelot","year":"2007","unstructured":"Didelot C, Lanneau D, Brunet M, Joly AL, De Thonel A, Chiosis G, Garrido C: Anti-cancer therapeutic approaches based on intracellular and extracellular heat shock proteins. Curr Med Chem 2007, 14(27):2839\u20132847. 10.2174\/092986707782360079","journal-title":"Curr Med Chem"},{"issue":"1-2","key":"4388_CR11","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.drudis.2007.10.007","volume":"13","author":"DB Solit","year":"2008","unstructured":"Solit DB, Chiosis G: Development and application of Hsp90 inhibitors. Drug Discov Today 2008, 13(1\u20132):38\u201343. 10.1016\/j.drudis.2007.10.007","journal-title":"Drug Discov Today"},{"issue":"2","key":"4388_CR12","first-page":"547","volume":"54","author":"TM Gress","year":"1994","unstructured":"Gress TM, Mullerpillasch F, Weber C, Lerch MM, Friess H, Buchler M, Beger HG, Adler G: Differential Expression of Heat-Shock Proteins in Pancreatic-Carcinoma. Cancer Res 1994, 54(2):547\u2013551.","journal-title":"Cancer Res"},{"issue":"4","key":"4388_CR13","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1002\/ijc.2910510418","volume":"51","author":"M Ferrarini","year":"1992","unstructured":"Ferrarini M, Heltai S, Zocchi MR, Rugarli C: Unusual Expression and Localization of Heat-Shock Proteins in Human Tumor-Cells. Int J Cancer 1992, 51(4):613\u2013619. 10.1002\/ijc.2910510418","journal-title":"Int J Cancer"},{"issue":"2","key":"4388_CR14","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.canlet.2003.08.032","volume":"206","author":"P Workman","year":"2004","unstructured":"Workman P: Combinatorial attack on multistep oncogenesis by inhibiting the Hsp90 molecular chaperone. Cancer Lett 2004, 206(2):149\u2013157. 10.1016\/j.canlet.2003.08.032","journal-title":"Cancer Lett"},{"issue":"1","key":"4388_CR15","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.cell.2007.07.036","volume":"131","author":"AJ McClellan","year":"2007","unstructured":"McClellan AJ, Xia Y, Deutschbauer AM, Davis RW, Gerstein M, Frydman J: Diverse cellular functions of the Hsp90 molecular chaperone uncovered using systems approaches. Cell 2007, 131(1):121\u2013135. 10.1016\/j.cell.2007.07.036","journal-title":"Cell"},{"issue":"3","key":"4388_CR16","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S1535-6108(03)00029-1","volume":"3","author":"JS Isaacs","year":"2003","unstructured":"Isaacs JS, Xu WP, Neckers L: Heat shock protein 90 as a molecular target for cancer therapeutics. Cancer Cell 2003, 3(3):213\u2013217. 10.1016\/S1535-6108(03)00029-1","journal-title":"Cancer Cell"},{"issue":"3","key":"4388_CR17","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1002\/jcp.1131","volume":"188","author":"K Richter","year":"2001","unstructured":"Richter K, Buchner J: Hsp90: Chaperoning signal transduction. J Cell Physiol 2001, 188(3):281\u2013290. 10.1002\/jcp.1131","journal-title":"J Cell Physiol"},{"issue":"2","key":"4388_CR18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/153537020322800201","volume":"228","author":"WB Pratt","year":"2003","unstructured":"Pratt WB, Toft DO: Regulation of signaling protein function and trafficking by the hsp90\/hsp70-based chaperone machinery. Exp Biol Med 2003, 228(2):111\u2013133.","journal-title":"Exp Biol Med"},{"issue":"10","key":"4388_CR19","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1038\/nrc1716","volume":"5","author":"L Whitesell","year":"2005","unstructured":"Whitesell L, Lindquist SL: HSP90 and the chaperoning of cancer. Nat Rev Cancer 2005, 5(10):761\u2013772. 10.1038\/nrc1716","journal-title":"Nat Rev Cancer"},{"issue":"19","key":"4388_CR20","doi-asserted-by":"publisher","first-page":"3758","DOI":"10.1016\/j.febslet.2007.05.040","volume":"581","author":"MV Powers","year":"2007","unstructured":"Powers MV, Workman P: Inhibitors of the heat shock response: Biology and pharmacology. Febs Lett 2007, 581(19):3758\u20133769. 10.1016\/j.febslet.2007.05.040","journal-title":"Febs Lett"},{"issue":"9","key":"4388_CR21","doi-asserted-by":"publisher","first-page":"733","DOI":"10.2174\/0929867033457818","volume":"10","author":"L Neckers","year":"2003","unstructured":"Neckers L: Development of small molecule Hsp90 inhibitors: Utilizing both forward and reverse chemical genomics for drug identification. Curr Med Chem 2003, 10(9):733\u2013739. 10.2174\/0929867033457818","journal-title":"Curr Med Chem"},{"issue":"18","key":"4388_CR22","doi-asserted-by":"publisher","first-page":"8324","DOI":"10.1073\/pnas.91.18.8324","volume":"91","author":"L Whitesell","year":"1994","unstructured":"Whitesell L, Mimnaugh EG, Decosta B, Myers CE, Neckers LM: Inhibition of Heat-Shock Protein Hsp90-Pp60(V-Src) Heteroprotein Complex-Formation by Benzoquinone Ansamycins - Essential Role for Stress Proteins in Oncogenic Transformation. P Natl Acad Sci USA 1994, 91(18):8324\u20138328. 10.1073\/pnas.91.18.8324","journal-title":"P Natl Acad Sci USA"},{"issue":"20","key":"4388_CR23","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1038\/sj.onc.1201790","volume":"16","author":"SV Sharma","year":"1998","unstructured":"Sharma SV, Agatsuma T, Nakano H: Targeting of the protein chaperone, HSP90, by the transformation suppressing agent, radicicol. Oncogene 1998, 16(20):2639\u20132645. 10.1038\/sj.onc.1201790","journal-title":"Oncogene"},{"issue":"10","key":"4388_CR24","first-page":"4003","volume":"61","author":"I Hostein","year":"2001","unstructured":"Hostein I, Robertson D, DiStefano F, Workman P, Clarke PA: Inhibition of signal transduction by the Hsp90 inhibitor 17-allylamino-17-demethoxygeldanamycin results in cytostasis and apoptosis. Cancer Res 2001, 61(10):4003\u20134009.","journal-title":"Cancer Res"},{"issue":"1-2","key":"4388_CR25","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.drup.2008.12.002","volume":"12","author":"YY Li","year":"2009","unstructured":"Li YY, Zhang T, Schwartz SJ, Sun DX: New developments in Hsp90 inhibitors as anti-cancer therapeutics: Mechanisms, clinical perspective and more potential. Drug Resist Update 2009, 12(1\u20132):17\u201327. 10.1016\/j.drup.2008.12.002","journal-title":"Drug Resist Update"},{"issue":"1","key":"4388_CR26","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1158\/1535-7163.MCT-07-0484","volume":"7","author":"T Zhang","year":"2008","unstructured":"Zhang T, Hamza A, Cao XH, Wang B, Yu SW, Zhan CG, Sun DX: A novel Hsp90 inhibitor to disrupt Hsp90\/Cdc37 complex against pancreatic cancer cells. Mol Cancer Ther 2008, 7(1):162\u2013170. 10.1158\/1535-7163.MCT-07-0484","journal-title":"Mol Cancer Ther"},{"issue":"24","key":"4388_CR27","doi-asserted-by":"publisher","first-page":"11942","DOI":"10.1158\/0008-5472.CAN-07-3162","volume":"67","author":"PJ Gray","year":"2007","unstructured":"Gray PJ, Stevenson MA, Calderwood SK: Targeting Cdc37 inhibits multiple signaling pathways and induces growth arrest in prostate cancer cells. Cancer Res 2007, 67(24):11942\u201311950. 10.1158\/0008-5472.CAN-07-3162","journal-title":"Cancer Res"},{"issue":"7","key":"4388_CR28","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/nrc2420","volume":"8","author":"PJ Gray","year":"2008","unstructured":"Gray PJ, Prince T, Cheng J, Stevenson MA, Calderwood SK: Targeting the oncogene and kinome chaperone CDC37. Nat Rev Cancer 2008, 8(7):491\u2013495. 10.1038\/nrc2420","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"4388_CR29","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.gde.2004.12.011","volume":"15","author":"LH Pearl","year":"2005","unstructured":"Pearl LH: Hsp90 and Cdc37 - a chaperone cancer conspiracy. Curr Opin Genet Dev 2005, 15(1):55\u201361. 10.1016\/j.gde.2004.12.011","journal-title":"Curr Opin Genet Dev"},{"issue":"5","key":"4388_CR30","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.molcel.2006.07.016","volume":"23","author":"CK Vaughan","year":"2006","unstructured":"Vaughan CK, Gohlke U, Sobott F, Good VM, Ali MMU, Prodromou C, Robinson CV, Saibil HR, Pearl LH: Structure of an Hsp90-Cdc37-Cdk4 complex. Mol Cell 2006, 23(5):697\u2013707. 10.1016\/j.molcel.2006.07.016","journal-title":"Mol Cell"},{"issue":"32","key":"4388_CR31","doi-asserted-by":"publisher","first-page":"20090","DOI":"10.1074\/jbc.273.32.20090","volume":"273","author":"AM Silverstein","year":"1998","unstructured":"Silverstein AM, Grammatikakis N, Cochran BH, Chinkers M, Pratt WB: P50(cdc37) binds directly to the catalytic domain of Raf as well as to a site on hsp90 that is topologically adjacent to the tetratricopeptide repeat binding site. J Biol Chem 1998, 273(32):20090\u201320095. 10.1074\/jbc.273.32.20090","journal-title":"J Biol Chem"},{"issue":"2","key":"4388_CR32","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/onc.2008.380","volume":"28","author":"JR Smith","year":"2009","unstructured":"Smith JR, Clarke PA, de Billy E, Workman P: Silencing the cochaperone CDC37 destabilizes kinase clients and sensitizes cancer cells to HSP90 inhibitors. Oncogene 2009, 28(2):157\u2013169. 10.1038\/onc.2008.380","journal-title":"Oncogene"},{"issue":"4","key":"4388_CR33","first-page":"269","volume":"11","author":"M Winters","year":"2006","unstructured":"Winters M: Ancient medicine, modern use: Withania somnifera and its potential role in integrative oncology. Alternative Medicine Review 2006, 11(4):269\u2013277.","journal-title":"Alternative Medicine Review"},{"issue":"6","key":"4388_CR34","doi-asserted-by":"publisher","first-page":"1499","DOI":"10.1016\/S0968-0896(01)00024-4","volume":"9","author":"H Matsuda","year":"2001","unstructured":"Matsuda H, Murakami T, Kishi A, Yoshikawa M: Structures of withanosides I, II, III, IV, V, VI, and VII, new withanolide glycosides, from the roots of Indian Withania somnifera Dunal. and inhibitory activity for tachyphylaxis to clonidine in isolated guinea-pig ileum. Bioorgan Med Chem 2001, 9(6):1499\u20131507. 10.1016\/S0968-0896(01)00024-4","journal-title":"Bioorgan Med Chem"},{"key":"4388_CR35","first-page":"1","volume-title":"Progress in the chemistry of natural organic products","author":"A Ray","year":"1994","unstructured":"Ray A, Gupta M: Withasteroids, a growing group of naturally occurring steroidal lactones. In Progress in the chemistry of natural organic products. Volume 63. Edited by: W, Kerby G, Moore R, Steglich W, Tamm C. New York: Springer-Verlag; 1994:1\u2013106."},{"issue":"2","key":"4388_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/0378-8741(92)90069-4","volume":"37","author":"MK Alhindawi","year":"1992","unstructured":"Alhindawi MK, Alkhafaji SH, Abdulnabi MH: Antigranuloma Activity of Iraqi Withania-Somnifera. J Ethnopharmacol 1992, 37(2):113\u2013116. 10.1016\/0378-8741(92)90069-4","journal-title":"J Ethnopharmacol"},{"key":"4388_CR37","first-page":"334","volume":"5","author":"L Mishra","year":"2000","unstructured":"Mishra L, Singh B, Dagenias S: Scientific basis for the therapeutic use of Withania somnifera (ashwagandha): a review. Altern Med Rev 2000, 5: 334\u2013336.","journal-title":"Altern Med Rev"},{"issue":"3","key":"4388_CR38","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1016\/j.phymed.2003.07.012","volume":"12","author":"M Owais","year":"2005","unstructured":"Owais M, Sharad KS, Shehbaz A, Saleemuddin M: Antibacterial efficacy of Withania somnifera (ashwagandha) an indigenous medicinal plant against experimental murine salmonellosis. Phytomedicine 2005, 12(3):229\u2013235. 10.1016\/j.phymed.2003.07.012","journal-title":"Phytomedicine"},{"issue":"1","key":"4388_CR39","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0378-8741(00)00309-3","volume":"74","author":"A Bhattacharya","year":"2001","unstructured":"Bhattacharya A, Ghosal S, Bhattacharya SK: Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum. J Ethnopharmacol 2001, 74(1):1\u20136. 10.1016\/S0378-8741(00)00309-3","journal-title":"J Ethnopharmacol"},{"issue":"6","key":"4388_CR40","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/(SICI)1099-1573(199809)12:6<451::AID-PTR328>3.0.CO;2-C","volume":"12","author":"SK Kulkarni","year":"1998","unstructured":"Kulkarni SK, George B, Mathur R: Protective effect of Withania somnifera root extract on electrographic activity in a lithium-pilocarpine model of status epilepticus. Phytotherapy Research 1998, 12(6):451\u2013453. Publisher Full Text 10.1002\/(SICI)1099-1573(199809)12:6<451::AID-PTR328>3.0.CO;2-C","journal-title":"Phytotherapy Research"},{"issue":"2","key":"4388_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1055\/s-2001-11494","volume":"67","author":"M Furmanowa","year":"2001","unstructured":"Furmanowa M, Gajdzis-Kuls D, Ruszkowska J, Czarnocki Z, Obidoska G, Sadowska A, Rani R, Upadhyay SN: In vitro propagation of Withania somnifera and isolation of withanolides with immunosuppressive activity. Planta Med 2001, 67(2):146\u2013149. 10.1055\/s-2001-11494","journal-title":"Planta Med"},{"issue":"1","key":"4388_CR42","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3109\/02841869609098486","volume":"35","author":"AC Sharada","year":"1996","unstructured":"Sharada AC, Solomon FE, Devi PU, Udupa N, Srinivasan KK: Antitumor and radiosensitizing effects of withaferin a on mouse Ehrlich ascites carcinoma in vivo. Acta Oncol 1996, 35(1):95\u2013100. 10.3109\/02841869609098486","journal-title":"Acta Oncol"},{"issue":"4","key":"4388_CR43","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.bcp.2009.09.017","volume":"79","author":"YK Yu","year":"2010","unstructured":"Yu YK, Hamza A, Zhang T, Gu MC, Zou P, Newman B, Li YY, Gunatilaka AAL, Zhan CG, Sun DX: Withaferin A targets heat shock protein 90 in pancreatic cancer cells. Biochem Pharmacol 2010, 79(4):542\u2013551. 10.1016\/j.bcp.2009.09.017","journal-title":"Biochem Pharmacol"},{"issue":"5","key":"4388_CR44","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.phymed.2003.05.004","volume":"11","author":"S Mathur","year":"2004","unstructured":"Mathur S, Kaur P, Sharma M, Katyal A, Singh B, Tiwari M, Chandra R: The treatment of skin carcinoma, induced by UVB radiation, using 1-oxo-5 beta,6 beta-epoxy-witha-2-enolide, isolated from the roots of Withania somnifera, in a rat model. Phytomedicine 2004, 11(5):452\u2013460. 10.1016\/j.phymed.2003.05.004","journal-title":"Phytomedicine"},{"issue":"6","key":"4388_CR45","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1111\/j.1460-9568.2006.04664.x","volume":"23","author":"T Kuboyama","year":"2006","unstructured":"Kuboyama T, Tohda C, Komatsu K: Withanoside IV and its active metabolite, sominone, attenuate A beta(25\u201335)-induced neurodegeneration. Eur J Neurosci 2006, 23(6):1417\u20131426. 10.1111\/j.1460-9568.2006.04664.x","journal-title":"Eur J Neurosci"},{"issue":"1-2","key":"4388_CR46","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1159\/000085384","volume":"23","author":"C Tohda","year":"2005","unstructured":"Tohda C, Kuboyama T, Komatsu K: Search for natural products related to regeneration of the neuronal network. Neurosignals 2005, 23(1\u20132):34\u201345. 10.1159\/000085384","journal-title":"Neurosignals"},{"issue":"6","key":"4388_CR47","doi-asserted-by":"publisher","first-page":"3885","DOI":"10.1074\/jbc.M806715200","volume":"284","author":"S Sreeramulu","year":"2009","unstructured":"Sreeramulu S, Jonker HRA, Langer T, Richter C, Lancaster CRD, Schwalbe H: The Human Cdc37.Hsp90 Complex Studied by Heteronuclear NMR Spectroscopy. J Biol Chem 2009, 284(6):3885\u20133896. 10.1074\/jbc.M806715200","journal-title":"J Biol Chem"},{"key":"4388_CR48","unstructured":"NCBI-PubChem Compound database[http:\/\/pubchem.ncbi.nlm.nih.gov\/]"},{"issue":"9","key":"4388_CR49","doi-asserted-by":"publisher","first-page":"2309","DOI":"10.1021\/ja955032e","volume":"118","author":"WD Cornell","year":"1996","unstructured":"Cornell WD, Cieplak P, Bayly CI, Gould IR, Merz KM, Ferguson DM, Spellmeyer DC, Fox T, Caldwell JW, Kollman PA: A second generation force field for the simulation of proteins, nucleic acids, and organic molecules. J Am Chem Soc 1996, 118(9):2309\u20132309. 10.1021\/ja955032e","journal-title":"J Am Chem Soc"},{"issue":"2","key":"4388_CR50","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/S0092-8674(00)80203-2","volume":"89","author":"CE Stebbins","year":"1997","unstructured":"Stebbins CE, Russo AA, Schneider C, Rosen N, Hartl FU, Pavletich NP: Crystal structure of an Hsp90-geldanamycin complex: Targeting of a protein chaperone by an antitumor agent. Cell 1997, 89(2):239\u2013250. 10.1016\/S0092-8674(00)80203-2","journal-title":"Cell"},{"issue":"2","key":"4388_CR51","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1379\/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2","volume":"8","author":"M MacLean","year":"2003","unstructured":"MacLean M, Picard D: Cdc37 goes beyond Hsp90 and kinases. Cell Stress Chaperon 2003, 8(2):114\u2013119. Publisher Full Text 10.1379\/1466-1268(2003)008<0114:CGBHAK>2.0.CO;2","journal-title":"Cell Stress Chaperon"},{"issue":"43","key":"4388_CR52","doi-asserted-by":"publisher","first-page":"12577","DOI":"10.1021\/bi035138j","volume":"42","author":"JY Shao","year":"2003","unstructured":"Shao JY, Irwin A, Hartson SD, Malts RL: Functional dissection of Cdc37: Characterization of domain structure and amino acid residues critical for protein kinase binding. Biochemistry-Us 2003, 42(43):12577\u201312588. 10.1021\/bi035138j","journal-title":"Biochemistry-Us"},{"issue":"4","key":"4388_CR53","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jmb.2004.05.007","volume":"340","author":"W Zhang","year":"2004","unstructured":"Zhang W, Hirshberg M, McLaughlin SH, Lazar GA, Grossmann JG, Nielsen PR, Sobott F, Robinson CV, Jackson SE, Laue ED: Biochemical and structural studies of the interaction of Cdc37 with Hsp90. J Mol Biol 2004, 340(4):891\u2013907. 10.1016\/j.jmb.2004.05.007","journal-title":"J Mol Biol"},{"issue":"1","key":"4388_CR54","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/S0092-8674(03)01027-4","volume":"116","author":"SM Roe","year":"2004","unstructured":"Roe SM, Ali MMU, Meyer P, Vaughan CK, Panaretou B, Piper PW, Prodromou C, Pearl LH: The mechanism of Hsp90 regulation by the protein kinase-specific cochaperone p50(cdc37). Cell 2004, 116(1):87\u201398. 10.1016\/S0092-8674(03)01027-4","journal-title":"Cell"},{"issue":"16","key":"4388_CR55","doi-asserted-by":"publisher","first-page":"4383","DOI":"10.1093\/emboj\/19.16.4383","volume":"19","author":"C Prodromou","year":"2000","unstructured":"Prodromou C, Panaretou B, Chohan S, Siligardi G, O'Brien R, Ladbury JE, Roe SM, Piper PW, Pearl LH: The ATPase cycle of Hsp90 drives a molecular 'clamp' via transient dimerization of the N-terminal domains. Embo J 2000, 19(16):4383\u20134392. 10.1093\/emboj\/19.16.4383","journal-title":"Embo J"},{"issue":"14","key":"4388_CR56","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","volume":"19","author":"GM Morris","year":"1998","unstructured":"Morris GM, Goodsell DS, Halliday RS, Huey R, Hart WE, Belew RK, Olson AJ: Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function. J Comput Chem 1998, 19(14):1639\u20131662. Publisher Full Text 10.1002\/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B","journal-title":"J Comput Chem"},{"issue":"1","key":"4388_CR57","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1124\/mol.61.1.20","volume":"61","author":"O Dym","year":"2002","unstructured":"Dym O, Xenarios I, Ke HM, Colicelli J: Molecular docking of competitive phosphodiesterase inhibitors. Mol Pharmacol 2002, 61(1):20\u201325. 10.1124\/mol.61.1.20","journal-title":"Mol Pharmacol"},{"issue":"2","key":"4388_CR58","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1002\/(SICI)1097-0134(19990201)34:2<173::AID-PROT3>3.0.CO;2-F","volume":"34","author":"MS Rao","year":"1999","unstructured":"Rao MS, Olson AJ: Modelling of Factor Xa-inhibitor complexes: A computational flexible docking approach. Proteins 1999, 34(2):173\u2013183. 10.1002\/(SICI)1097-0134(19990201)34:2<173::AID-PROT3>3.0.CO;2-F","journal-title":"Proteins"},{"issue":"1","key":"4388_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","volume":"9","author":"DS Goodsell","year":"1996","unstructured":"Goodsell DS, Morris GM, Olson AJ: Automated docking of flexible ligands: Applications of AutoDock. J Mol Recognit 1996, 9(1):1\u20135. Publisher Full Text 10.1002\/(SICI)1099-1352(199601)9:1<1::AID-JMR241>3.0.CO;2-6","journal-title":"J Mol Recognit"},{"issue":"7","key":"4388_CR60","doi-asserted-by":"publisher","first-page":"1729","DOI":"10.1110\/ps.0202302","volume":"11","author":"C Hetenyi","year":"2002","unstructured":"Hetenyi C, van der Spoel D: Efficient docking of peptides to proteins without prior knowledge of the binding site. Protein Sci 2002, 11(7):1729\u20131737. 10.1110\/ps.0202302","journal-title":"Protein Sci"},{"issue":"4","key":"4388_CR61","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1007\/BF00124499","volume":"10","author":"GM Morris","year":"1996","unstructured":"Morris GM, Goodsell DS, Huey R, Olson AJ: Distributed automated docking of flexible ligands to proteins: Parallel applications of AutoDock 2.4. J Comput Aid Mol Des 1996, 10(4):293\u2013304. 10.1007\/BF00124499","journal-title":"J Comput Aid Mol Des"},{"key":"4388_CR62","volume-title":"The PyMOL Molecular Graphics System 2002","author":"W DeLano","year":"2002","unstructured":"DeLano W: The PyMOL Molecular Graphics System 2002. San Carlos, CA: DeLano Scientific; 2002."},{"issue":"7","key":"4388_CR63","doi-asserted-by":"publisher","first-page":"632","DOI":"10.2174\/092986607781483831","volume":"14","author":"A Gupta","year":"2007","unstructured":"Gupta A, Gandhimathi A, Sharma P, Jayaram B: ParDOCK: An all atom energy based Monte Carlo docking protocol for protein-ligand complexes. Protein Peptide Lett 2007, 14(7):632\u2013646. 10.2174\/092986607781483831","journal-title":"Protein Peptide Lett"},{"key":"4388_CR64","volume-title":"AMBER 11","author":"DT Case DA","year":"2010","unstructured":"Case DA DT, Cheatham TE, Simmerling CL, Wang J, Duke RE, Luo R, Walker RC, Zhang W, Merz KM, Roberts B, Wang B, Hayik S, Roitberg A, Seabra G, Kolossv\u00e1ry I, Wong IF, Paesani F, Vanicek J, Wu X, Brozell SR, Steinbrecher T, Gohlke H, Cai Q, Ye X, Wang J, Hsieh MJ, Cui G, Roe DR, Mathews DH, Seetin MG, Sagui C, Babin V, Luchko T, Gusarov S, Kovalenko A, Kollman PA: AMBER 11. San Francisco: University of California; 2010."},{"issue":"2","key":"4388_CR65","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1063\/1.445869","volume":"79","author":"WL Jorgensen","year":"1983","unstructured":"Jorgensen WL, Chandrasekhar J, Madura JD, Impey RW, Klein ML: Comparison of Simple Potential Functions for Simulating Liquid Water. J Chem Phys 1983, 79(2):926\u2013935. 10.1063\/1.445869","journal-title":"J Chem Phys"},{"issue":"2","key":"4388_CR66","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1002\/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P","volume":"21","author":"A Jakalian","year":"2000","unstructured":"Jakalian A, Bush BL, Jack DB, Bayly CI: Fast, efficient generation of high-quality atomic Charges. AM1-BCC model: I. Method. J Comput Chem 2000, 21(2):132\u2013146. Publisher Full Text 10.1002\/(SICI)1096-987X(20000130)21:2<132::AID-JCC5>3.0.CO;2-P","journal-title":"J Comput Chem"},{"issue":"8","key":"4388_CR67","doi-asserted-by":"publisher","first-page":"3684","DOI":"10.1063\/1.448118","volume":"81","author":"HJC Berendsen","year":"1984","unstructured":"Berendsen HJC, Postma JPM, Vangunsteren WF, Dinola A, Haak JR: Molecular-Dynamics with Coupling to an External Bath. J Chem Phys 1984, 81(8):3684\u20133690. 10.1063\/1.448118","journal-title":"J Chem Phys"},{"issue":"3","key":"4388_CR68","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","volume":"23","author":"JP Ryckaert","year":"1977","unstructured":"Ryckaert JP, Ciccotti G, Berendsen HJC: Numerical-Integration of Cartesian Equations of Motion of a System with Constraints - Molecular-Dynamics of N-Alkanes. J Comput Phys 1977, 23(3):327\u2013341. 10.1016\/0021-9991(77)90098-5","journal-title":"J Comput Phys"},{"issue":"19","key":"4388_CR69","doi-asserted-by":"publisher","first-page":"8577","DOI":"10.1063\/1.470117","volume":"103","author":"U Essmann","year":"1995","unstructured":"Essmann U, Perera L, Berkowitz ML, Darden T, Lee H, Pedersen LG: A Smooth Particle Mesh Ewald Method. J Chem Phys 1995, 103(19):8577\u20138593. 10.1063\/1.470117","journal-title":"J Chem Phys"}],"container-title":["BMC Bioinformatics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2105-12-S1-S30.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T13:44:16Z","timestamp":1630503856000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcbioinformatics.biomedcentral.com\/articles\/10.1186\/1471-2105-12-S1-S30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2,15]]},"references-count":69,"journal-issue":{"issue":"S1","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["4388"],"URL":"https:\/\/doi.org\/10.1186\/1471-2105-12-s1-s30","relation":{},"ISSN":["1471-2105"],"issn-type":[{"value":"1471-2105","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2,15]]},"assertion":[{"value":"15 February 2011","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"S30"}}